NCT06232460View on ClinicalTrials.gov

An Open Label, Dose-escalation Study, Assessing the Safety and Tolerability of a Collagen Peptide

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 8, 2024

Primary Completion Date

July 29, 2024

Study Completion Date

July 29, 2024

Conditions
Tolerance
Interventions
DIETARY_SUPPLEMENT

H80

5g, 10g \& 20g

Trial Locations (1)

60611

Atlantia Clinical Trials, Chicago

All Listed Sponsors
lead

Rousselot BVBA

INDUSTRY

NCT06232460 - An Open Label, Dose-escalation Study, Assessing the Safety and Tolerability of a Collagen Peptide | Biotech Hunter | Biotech Hunter